Professor
University of California San Francisco
San Francisco, CA, United States
Peter Hunt is a Professor of Medicine in the Division of Experimental Medicine at the University of California San Francisco (UCSF), Co-Director of the UCSF-Bay Area Center for AIDS Research for Basic and Translational Science, and Associate Chief for Research for the Zuckerberg San Francisco General Hospital (ZSFG)-UCSF Department of Medicine. His primary research focus is on the inflammatory consequences of HIV infection. His translational research program seeks to understand the causes and consequences of persistent immune activation and its impact on aging-associated multi-morbidity and mortality in treated HIV infection, as well as its impact on HIV persistence. He also conducts clinical trials of novel immune-based interventions designed to decrease immune activation and previously served as Chair of the Inflammation Committee of the AIDS Clinical Trials Group (ACTG). Dr. Hunt led translational research programs in Uganda, focused on the determinants of immune recovery during HIV therapy in that setting, and helped develop a large mucosal immunology program at ZSFG focused on the impact of HIV on gut-associated lymphoid tissue on HIV pathogenesis. His laboratory currently focuses on the immune defects that drive morbidity and mortality in treated HIV, with a specific focus on the role of CMV co-infection as an important mediator. He has also recently extended his CMV work to address its impact on COVID-19 pathogenesis.
Disclosure(s): Gilead Biosciences: Grant/Research Support (Ongoing), Honoraria (Ongoing); Merck Sharp & Dohme Corporation: Advisor/Consultant (Terminated, August 31, 2023), donated drug for NIH-sponsored clinical trial (Terminated, August 31, 2023); Viiv Healthcare: Advisor/Consultant (Terminated, March 30, 2023), Honoraria (Terminated, March 30, 2023)
Wednesday, October 16, 2024
1:30 PM – 3:15 PM US PT
18 - What's Hot in HIV Basic Sciences
Wednesday, October 16, 2024
1:30 PM – 1:55 PM US PT